Literature DB >> 2190419

The role of physicians as medical review officers in workplace drug testing programs. In pursuit of the last nanogram.

H W Clark1.   

Abstract

In discussing the role of physicians in workplace drug testing programs, I focus on the recent Department of Transportation regulations that require drug testing in such regulated industries as interstate trucking, air transportation, mass transit, and the railroads. These regulations require that applicable drug testing programs employ physicians as medical review officers to evaluate positive tests that have been screened and confirmed by different techniques to determine if there is a legal medical explanation for the result. The drug testing program tests for the presence of amphetamine, cocaine, tetrahydrocannabinol, opiates, and phencyclidine. If an employee testing positive has an acceptable medical explanation, the result is to be reported as negative. Little practical advice exists for medical review officers, and they must be aware of key elements of the regulations and potential trouble spots.

Entities:  

Keywords:  Department of Transportation; Health Care and Public Health

Mesh:

Year:  1990        PMID: 2190419      PMCID: PMC1002404     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  25 in total

1.  Impact of adulterants on RIA analysis of urine for drugs of abuse.

Authors:  J T Cody; R H Schwarzhoff
Journal:  J Anal Toxicol       Date:  1989 Sep-Oct       Impact factor: 3.367

2.  Drug testing: ethical considerations.

Authors:  E McNeely
Journal:  AAOHN J       Date:  1988-03

3.  Drug testing in the military--technical and legal problems.

Authors:  J Irving
Journal:  Clin Chem       Date:  1988-03       Impact factor: 8.327

4.  Screening: urine drug tests.

Authors:  D I Canavan
Journal:  Md Med J       Date:  1987-03

5.  Collecting a reliable urine specimen for drug analysis.

Authors:  M Andersen; K Albright; M Serowoky
Journal:  J Nurs Adm       Date:  1987-01       Impact factor: 1.737

6.  Drug testing in the workplace--are methods legally defensible? A survey of experts, arbitrators, and testing laboratories.

Authors:  D W Hoyt; R E Finnigan; T Nee; T F Shults; T J Butler
Journal:  JAMA       Date:  1987 Jul 24-31       Impact factor: 56.272

Review 7.  Analytical and technical aspects of testing for drug abuse: confirmatory procedures.

Authors:  M A Peat
Journal:  Clin Chem       Date:  1988-03       Impact factor: 8.327

Review 8.  Legal issues related to drug testing in the clinical laboratory.

Authors:  R T Chamberlain
Journal:  Clin Chem       Date:  1988-03       Impact factor: 8.327

9.  Passive inhalation of marijuana smoke: urinalysis and room air levels of delta-9-tetrahydrocannabinol.

Authors:  E J Cone; R E Johnson; W D Darwin; D Yousefnejad; L D Mell; B D Paul; J Mitchell
Journal:  J Anal Toxicol       Date:  1987 May-Jun       Impact factor: 3.367

10.  Metabolism of (-) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefit: a biochemical assessment.

Authors:  F Karoum; L W Chuang; T Eisler; D B Calne; M R Liebowitz; F M Quitkin; D F Klein; R J Wyatt
Journal:  Neurology       Date:  1982-05       Impact factor: 9.910

View more
  2 in total

Review 1.  Pre-employment urine drug testing of hospital employees: future questions and review of current literature.

Authors:  M R Levine; W P Rennie
Journal:  Occup Environ Med       Date:  2004-04       Impact factor: 4.402

Review 2.  Addiction and substance abuse in anesthesiology.

Authors:  Ethan O Bryson; Jeffrey H Silverstein
Journal:  Anesthesiology       Date:  2008-11       Impact factor: 7.892

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.